Why are you looking at Mark Cuban Cost Plus Drug Company Pbc?
Email me when a Mark Cuban Cost Plus Drug Company Pbc recompete window opens.
Capability
Service linesRESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Work mix: 100% prime · 0% sub · primary NAICS 541715 / PSC AC12 NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
Where they win
Sole agencyRecompete exposure: Low · 1 in 24mo
Mark Cuban Cost Plus Drug Company Pbc has an estimated $1.4M in contracts returning to market over the next 24 months.
Agency buyer map
1 buyersRecompete exposure
LowMark Cuban Cost Plus Drug Company Pbc has an estimated $1.4M in contracts returning to market over the next 24 months.
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Mark Cuban Cost Plus Drug Company Pbc hold?
Mark Cuban Cost Plus Drug Company Pbc (UEI N8P7MQ937WN7) shows $1.6M across 2 award actions in SCOUT’s public USASpending-backed profile, with Department of Defense (DOD) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Mark Cuban Cost Plus Drug Company Pbc have?
Mark Cuban Cost Plus Drug Company Pbc shows $1.6M across 2 award actions. SCOUT tracks 1 incumbent recompetes ($1.4M) returning to market in the next 24 months.
Which agencies does Mark Cuban Cost Plus Drug Company Pbc work with?
Mark Cuban Cost Plus Drug Company Pbc’s firm-wide obligated mix is led by Department of Defense (DOD) (100%).
What is the UEI for Mark Cuban Cost Plus Drug Company Pbc?
The Unique Entity ID (UEI) for Mark Cuban Cost Plus Drug Company Pbc is N8P7MQ937WN7.
Does Mark Cuban Cost Plus Drug Company Pbc have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (Low exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Mark Cuban Cost Plus Drug Company Pbc — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.